Clinical Study Site

Ankara 06590

1 studies enrolling now · 2 studies all time

What they study most

Fabry Disease, Non-Small Cell Lung Cancer

Studies at this site

• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1 — Recruiting now
• Open-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry Disease — Completed